GenScript Seeks Long-term Collaboration Opportunities By Offering Special Partnership Promotion For Gene Synthesis

 Apr 19, 2009

PISCATAWAY, N.J., Apr. 19, 2009-Internationally recognized biology contract research organization GenScript USA Inc. announces its special partnership promotion for gene synthesis service, which aims to establish a long-term, high-volume, and preferred vendor contract with its partners by offering them specially discounted service prices. Customers may quote from our online system or via email and phone.

Under current economic conditions, GenScript hopes to cultivate long-term partnerships by working together with its partners in a flexible manner, fitting their budget. With its solid financial performance, the company claims to deliver assured, reliable, and sustainable services to its valuable customers and clients.

The campaign, commencing on Apr 8th, 2009, is predicted to accelerate the process for GenScript to become the preferred vendor for other biotech and pharmaceutical companies that demand large-scale molecular biology services involving genes. Clients may quote from GenScripts online system.

GenScripts gene services include gene synthesis, plasmid preparation, cloning, mutagenesis, vector construction, ORF Cloning, RNAi services and many more. To date, GenScript holds a record of having synthesized over 60,000 genes, including genes of over 50,000 bp in length.

GenScript Corporation is a reliable outsourcing partner, providing a wide array of services to augment all stages of the drug discovery and development. The company's services include high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, and custom stable cell line development. GenScript also offers a selection of biological reagents to life science researchers in both industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey.

# # # #

For further information, please contact:
Sally Wang
Executive Vice President
GENSCRIPT USA INC.
1-(732) 885-9188

Source: http://www.genscript.com/gene_synthesis.html

Your Innovation Partner in Drug Discovery!